Patch Biosciences
Patch Biosciences was a synthetic-biology and machine-learning company, founded in 2020 and based in New York, that built an AI platform for genetic sequence design — computationally engineering DNA "cargos" and regulatory elements to make gene and RNA therapies more effective, specific, and durable. It was backed by Andreessen Horowitz (a16z) Bio + Health, Casdin Capital, and S32. Patch Biosciences was acquired by Ginkgo Bioworks in early 2024 and folded into Ginkgo's genetic-medicine services; it no longer operates as an independent company. Its former standalone website (patch.bio) is now parked and no public developer portal, API, or documentation surface exists. This profile is retained in the API Evangelist network as an acquired/defunct company record surfaced from a16z portfolio enrichment.
Patch Biosciences is profiled on the APIs.io network. Tagged areas include Company, Synthetic Biology, Genetic Medicine, Gene Therapy, and Machine Learning.
Kin Score
Resources
Company 2
The organization behind the API